04 October 2022 : Original article
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in Pakistan
Nida Saleem 12ABDEF*, Saima Bashir 1ABE, Asrar Khan 23ADEFG, Syed Nayer Mahmud 1AE, Maliha Aziz 4CD, Merina Khan 1BEFDOI: 10.12659/AOT.937688
Ann Transplant 2022; 27:e937688
Table 1 Pre and post-transplant characteristics of kidney transplant recipients.
Pre-transplant characteristics | Post-transplant characteristics | ||||
---|---|---|---|---|---|
12±5 SD | |||||
ATGe | 29/50 | 58% | |||
Basiliximab | 14/50 | 28% | |||
None | 7/50 | 14% | |||
35.38±11.690 SD | |||||
<7 days | 32/50 | 64% | |||
≥7 days | 18/50 | 36% | |||
1.20±0.41 SD | |||||
Male | 41/50 | 82% | |||
Female | 9/50 | 18% | |||
a | 23.673±4.5685 SD | f | 11/50 | 22% | |
12/50 | 24% | ||||
Diabetes mellitus | 19/50 | 38% | |||
Hypertension | 46/50 | 92% | |||
Hepatitis B | 6/50 | 12% | |||
Hepatitis C | 9/50 | 18% | |||
Stroke | 3/50 | 6% | |||
History of smoking | 12/50 | 24% | |||
4/50 | 8% | ||||
ATNg | 8/12 | 66.6% | |||
Rejection | 3/12 | 25% | |||
Others | 1/12 | 8.33% | |||
b | 18/50 | 36% | |||
Diabetic Nephropathy | 9/50 | 18% | |||
Hypertensive Nephropathy | 10/50 | 20% | |||
Reflux Nephropathy | 5/50 | 10% | |||
IgA Nephropathy | 7/50 | 14% | |||
FSGSc | 5/50 | 10% | |||
Other Glomerulonephritis | 3/50 | 6% | |||
Obstructive Nephropathy | 8/50 | 16% | |||
Others | 2/50 | 4% | |||
Pre-emptive transplant | 8/50 | 16% | |||
<6 months | 22/50 | 44% | <10 | 13/50 | 26% |
7–12months | 7/50 | 14% | >10 | 37/50 | 74% |
>1 year | 13/50 | 26% | |||
d | |||||
0 | 9/50 | 18% | Face to face | 21/50 | 42% |
1–5 | 28/50 | 56% | Telemedicine and face to face | 29/50 | 58% |
>5 | 13/50 | 26% | |||
a – Body mass index b – end stage renal disease c – focal segmental glomerulosclerosis d – Human leukocyte antigens e – anti-thymocyte globulin F – new onset diabetes after transplant g – acute tubular necrosis. |